Yayıncı "Ferrata Storti Foundation" WoS İndeksli Yayınlar Koleksiyonu için listeleme
Toplam kayıt 23, listelenen: 1-20
-
The Acute Clinical and Laboratory Consequences of Oral Mucositis Developed After Remission Induction Chemotherapy in Acute Leukemia Patients
(Ferrata Storti Foundation, 2016)… -
Chronic Lymphocytic Leukemia Md Anderson Cancer Center Prognostic Index Is Successful But Still Can Be Improved By Incorporating Serum Ldh Level
(Ferrata Storti Foundation, 2015)… -
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study
(Ferrata Storti Foundation, 2017)Intravenous rituximab plus chemotherapy is standard treatment for diffuse large B-cell lymphoma. A subcutaneous formulation of rituximab is expected to simplify and shorten drug preparation and administration, and to reduce ... -
Erdheim-Chester Disease Presented With Central Nervous System Involvement: A Case Report
(Ferrata Storti Foundation, 2013)… -
Generic Imatinib Mesylate Is As Effective As Original Glivec in the Management of Cml
(Ferrata Storti Foundation, 2015)… -
Initial Phase 2 Results of Ibrutinib Combined With Bortezomib/Dexamethasone in Previously Treated Patients With Multiple Myeloma
(Ferrata Storti Foundation, 2017)… -
Is Cd45 Expression Level Related To High Risk Definition in Childhood Pediatric B All?
(Ferrata Storti Foundation, 2015)… -
Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of 65 Patients
(Ferrata Storti Foundation, 2017)… -
Lmo2 Expression Does Not Effect Cytogenetic and Molecular Response in Cml Patients Treated With Imatinib
(Ferrata Storti Foundation, 2013)… -
Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis
(Ferrata Storti Foundation, 2016)Dyskeratosis congenita is a highly pleotropic genetic disorder. This heterogeneity can lead to difficulties in making an accurate diagnosis and delays in appropriate management. The aim of this study was to determine the ... -
Nivolumab For Relapsed Or Refractory Hodgkin Lymphoma: Experience in Turkey
(Ferrata Storti Foundation, 2017)… -
Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma
(Ferrata Storti Foundation, 2017)Activation of the phosphatidylinositol 3-kinase/mechanistic target of rapamycin pathway plays a role in the pathogenesis of non-Hodgkin lymphoma. This multicenter, open-label phase 2 study evaluated buparlisib (BKM120), a ... -
Progressive Decline of Hbsag Seroprevalance in Blood Donors in Northern Turkey: the Twenty One-Year Experience
(Ferrata Storti Foundation, 2015)… -
A Rare Case of Polycythemia Vera and Plasma Cell Myeloma in the Same Patient
(Ferrata Storti Foundation, 2018)… -
The Relationship Between Oxidant Injury and Insuline Resistance in Patients With Fanconi Aplastic Anemia
(Ferrata Storti Foundation, 2013)… -
Retrospective Analysis of Patients With Vitamin B12 Deficiency Who Were Followed and Treated in Pediatric Hematology Department
(Ferrata Storti Foundation, 2012)… -
Retrospective Evaluation of Chronic Idiopathic Thrombocytopenic Purpura Patients
(Ferrata Storti Foundation, 2013)…